These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12794215)

  • 41. Prevalence, susceptibility profile and proteinase production of yeasts causing vulvovaginitis in Turkish women.
    Ozcan SK; Budak F; Yucesoy G; Susever S; Willke A
    APMIS; 2006 Feb; 114(2):139-45. PubMed ID: 16519751
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antifungal susceptibilities, in vitro production of virulence factors and activities of ceragenins against Candida spp. isolated from vulvovaginal candidiasis.
    Hacioglu M; Guzel CB; Savage PB; Tan ASB
    Med Mycol; 2019 Apr; 57(3):291-299. PubMed ID: 29846682
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Can the diagnosis of recurrent vulvovaginal candidosis be improved by use of vaginal lavage samples and cultures on chromogenic agar?
    Novikova N; Rodrigues A; Mårdh PA
    Infect Dis Obstet Gynecol; 2002; 10(2):89-92. PubMed ID: 12530485
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral Candida isolates among HIV-infected subjects in Nigeria.
    Nweze EI; Ogbonnaya UL
    J Microbiol Immunol Infect; 2011 Jun; 44(3):172-7. PubMed ID: 21524610
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of Candida spp. in the vagina of a cohort of nulliparous pregnant women by culture and molecular methods: Is there an association between maternal vaginal and infant oral colonisation?
    Payne MS; Cullinane M; Garland SM; Tabrizi SN; Donath SM; Bennett CM; Amir LH
    Aust N Z J Obstet Gynaecol; 2016 Apr; 56(2):179-84. PubMed ID: 26437337
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period.
    Kucukates E; Erturan Z; Susever S; Yegenoglu Y
    APMIS; 2005 Apr; 113(4):278-83. PubMed ID: 15865609
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors.
    Kalkanci A; Güzel AB; Khalil II; Aydin M; Ilkit M; Kuştimur S
    Med Mycol; 2012 Aug; 50(6):585-93. PubMed ID: 22369624
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterisation of yeasts implicated in vulvovaginal candidosis in Irish women.
    al-Rawi N; Kavanagh K
    Br J Biomed Sci; 1999; 56(2):99-104. PubMed ID: 10695049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
    Dagi HT; Findik D; Senkeles C; Arslan U
    Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proanthocyanidin polymeric tannins from Stryphnodendron adstringens are effective against Candida spp. isolates and for vaginal candidiasis treatment.
    de Freitas ALD; Kaplum V; Rossi DCP; da Silva LBR; Melhem MSC; Taborda CP; de Mello JCP; Nakamura CV; Ishida K
    J Ethnopharmacol; 2018 Apr; 216():184-190. PubMed ID: 29325916
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Fungal diseases of vulva and vagina caused by Candida species].
    Stock I
    Med Monatsschr Pharm; 2010 Sep; 33(9):324-33; quiz 335-6. PubMed ID: 21192442
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fungal infection of cystic fibrosis patients - single center experience.
    Garczewska B; Jarzynka S; Kuś J; Skorupa W; Augustynowicz-Kopeć E
    Pneumonol Alergol Pol; 2016; 84(3):151-9. PubMed ID: 27238177
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Summary of the national seminar on diagnosis and treatment of female vulvar-vaginal diseases].
    Jiang L; Wang JL; Zhu L
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jul; 43(7):483-5. PubMed ID: 19080507
    [No Abstract]   [Full Text] [Related]  

  • 54. Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates.
    Lynch ME; Sobel JD
    J Med Vet Mycol; 1994; 32(4):267-74. PubMed ID: 7983571
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vaginopathic and proteolytic Candida species in outpatients attending a gynaecology clinic.
    Agatensi L; Franchi F; Mondello F; Bevilacqua RL; Ceddia T; De Bernardis F; Cassone A
    J Clin Pathol; 1991 Oct; 44(10):826-30. PubMed ID: 1960216
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trends in frequency and in vitro antifungal susceptibility patterns of Candida isolates from women attending the STD outpatients clinic of a tertiary care hospital in Northern Italy during the years 2002-2007.
    Asticcioli S; Sacco L; Daturi R; Matti C; Nucleo E; Zara F; Pagani L
    New Microbiol; 2009 Apr; 32(2):199-204. PubMed ID: 19579700
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genital yeast infections.
    Oriel JD; Partridge BM; Denny MJ; Coleman JC
    Br Med J; 1972 Dec; 4(5843):761-4. PubMed ID: 4566994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of antifungal treatment on the prevalence of yeasts in HIV-infected subjects.
    Patel M; Shackleton JT; Coogan MM
    J Med Microbiol; 2006 Sep; 55(Pt 9):1279-1284. PubMed ID: 16914661
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High rate of vaginal infections caused by non-C. albicans Candida species among asymptomatic women.
    Dan M; Poch F; Levin D
    Med Mycol; 2002 Aug; 40(4):383-6. PubMed ID: 12230217
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exoenzyme activity and possibility identification of Candida dubliniensis among Candida albicans species isolated from vaginal candidiasis.
    Jafari M; Salari S; Pakshir K; Zomorodian K
    Microb Pathog; 2017 Sep; 110():73-77. PubMed ID: 28642006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.